Liberian Ebola Survivor Praises Experimental Drug
People celebrate on the streets outside of West Point, which has been closed in by Liberian security forces to stop all movement the past week in a attempt to control the Ebola outbreak in Monrovia, Liberia, Saturday, August 30, 2014.
MONROVIA, LIBERIA (AP) — A Liberian health worker who recovered from Ebola after receiving an experimental drug urged the manufacturer to speed up its production and send it to Africa, while crowds celebrated in the streets Saturday after authorities reopened a slum that had been barricaded for more than a week to try to contain the disease.
Physician's assistant Kyndy Kobbah was expected to be released from hospital Saturday after she survived Ebola, which has been fatal in more than half the cases sweeping West Africa. Kobbah contracted the disease while working at a government-run hospital north of the capital.
In an interview with The Associated Press before her release, she said when she informed her family that she had been cured, the home exploded with joy "and the house is on fire right now" with celebration.
"I am very fine and all right, glory be to God," she said. "I trusted God that I was going to be healed." Kobbah urged the manufacturer of the experimental drug known as ZMapp to step up production. The company has said that all its supplies are exhausted and it will take months to make more.
"They need to make more Zmapp and send to us," she said. Doctors have said there is no way to know whether ZMapp made a difference or if survivors like Kobbah recovered on their own, as about 45 percent of people infected in this outbreak have. The drug had never been tested in humans before it was given to two Americans who were infected with Ebola in Liberia. They survived Ebola and were released from an Atlanta hospital.
However, a study released online Friday by the journal Nature found that ZMapp healed all 18 monkeys infected with the deadly virus. Meanwhile, tensions diminished Saturday in the West Point neighborhood of Liberia's capital after authorities lifted a blockade that had sparked unrest. Residents living in the area had feared running out of food and safe water on the peninsula.
Liberia's president had ordered the barricade on Aug. 19 after West Point residents stormed an Ebola health center several days earlier. Residents said they did not want sick people being brought into the community, although those staying at the center were only under observation during a 21-day incubation period.
Amid the melee, some protesters made off with blood-stained mattresses and other materials that could potentially spread the Ebola virus. Lifting the quarantine Saturday morning doesn't mean there is no Ebola in the West Point slum, said Information Minister Lewis Brown. Authorities, though, are more confident now that they can work with residents to screen for the sick, he said.
"They're comfortable with the way the leadership and the community is working with the health team to make sure that the community remains safe," he said. Liberia has been the hardest hit of the five countries with Ebola cases in West Africa, reporting at least 694 deaths among 1,378 cases. More than 3,000 cases have been reported across Liberia, Guinea, Sierra Leone and Nigeria, and on Friday Senegal announced its first case.
A student from Guinea who had been missing for several weeks showed up at a hospital in Dakar on Tuesday, seeking treatment but concealing that he had been in contact with other Ebola victims, Health Minister Awa Marie Coll Seck confirmed.
The next day, an epidemiological surveillance team in neighboring Guinea alerted Senegalese authorities that they had lost track of a person they were monitoring three weeks earlier, and that the person may have crossed into Senegal.
The student was tracked down in the Dakar hospital where he was confirmed with Ebola and immediately put into isolation where he is reported to be in satisfactory condition, Seck said. Authorities also sent out a team to disinfect the home where he was staying in Senegal.
Comments